Fragment-based covalent ligand discovery

W Lu, M Kostic, T Zhang, J Che, MP Patricelli… - RSC chemical …, 2021 - pubs.rsc.org
Targeted covalent inhibitors have regained widespread attention in drug discovery and have
emerged as powerful tools for basic biomedical research. Fueled by considerable …

Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?

Z Zhao, H Wu, L Wang, Y Liu, S Knapp, Q Liu… - ACS chemical …, 2014 - ACS Publications
The ATP site of kinases displays remarkable conformational flexibility when accommodating
chemically diverse small molecule inhibitors. The so-called activation segment, whose …

Protein-protein interaction (PPI) network: recent advances in drug discovery

A Athanasios, V Charalampos… - Current drug …, 2017 - ingentaconnect.com
Background: The investigation of the cellular components, their interactions and related
functions constitute the major conditions in order to understand the cell as an integrated …

KLIFS: a knowledge-based structural database to navigate kinase–ligand interaction space

OPJ Van Linden, AJ Kooistra, R Leurs… - Journal of medicinal …, 2014 - ACS Publications
Protein kinases regulate the majority of signal transduction pathways in cells and have
become important targets for the development of designer drugs. We present a systematic …

Systems pharmacology: network analysis to identify multiscale mechanisms of drug action

S Zhao, R Iyengar - Annual review of pharmacology and …, 2012 - annualreviews.org
Systems approaches have long been used in pharmacology to understand drug action at
the organ and organismal levels. The application of computational and experimental …

Mitochondrial Ca2+ Signaling in Health, Disease and Therapy

L Modesti, A Danese, V Angela Maria Vitto… - Cells, 2021 - mdpi.com
The divalent cation calcium (Ca2+) is considered one of the main second messengers
inside cells and acts as the most prominent signal in a plethora of biological processes. Its …

Experiences in fragment-based drug discovery

CW Murray, ML Verdonk, DC Rees - Trends in pharmacological sciences, 2012 - cell.com
Fragment-based drug discovery (FBDD) has become established in both industry and
academia as an alternative approach to high-throughput screening for the generation of …

Fragment-based drug discovery: advancing fragments in the absence of crystal structures

DA Erlanson, BJ Davis, W Jahnke - Cell Chemical Biology, 2019 - cell.com
Fragment-based drug discovery typically requires an interplay between screening methods,
structural methods, and medicinal chemistry. X-ray crystallography is generally the method …

A systematic approach to the discovery of protein–protein interaction stabilizers

DN Kenanova, EJ Visser, JM Virta, E Sijbesma… - ACS central …, 2023 - ACS Publications
Dysregulation of protein–protein interactions (PPIs) commonly leads to disease. PPI
stabilization has only recently been systematically explored for drug discovery despite being …

[HTML][HTML] Covalent fragment libraries in drug discovery

A Keeley, L Petri, P Ábrányi-Balogh, GM Keserű - Drug Discovery Today, 2020 - Elsevier
Highlights•Overview on available covalent warheads.•Design principles of covalent
fragment libraries.•Surrogate assay methodologies for testing reactivity.•Covalent screening …